Objective. To compare the characteristics of people with fibromyalgia (FM) with those with other forms of nonmalignant chronic pain.
Introduction
With an estimated prevalence of 1.1% to 6.4% of the general population, fibromyalgia (FM) is commonly acknowledged as a complex musculoskeletal disorder that is primarily diagnosed and managed in primary care [1] [2] [3] . The 2012 National Health Interview Survey (NHIS) estimated that 3.94 million US adults report severe levels of pain and somatic distress consistent with FM diagnostic criteria [4] . In 1990, the American College of Rheumatology (ACR) developed FM classification criteria that defined the condition as a combination of a history of generalized, widespread pain, defined as spinal, bilateral, upper and lower segment; present for at least three months; and pain in at least 11 of 18 specific tender point sites when digitally palpitated with approximately 4 kilograms of pressure [5] .
In 2010, the ACR issued a revised set of criteria that do not utilize a tender point examination due to concerns about the frequency and accuracy of tender point examination occurring in primary care [6] . Instead, emphasis is placed upon qualitative aspects of the narrative of illness, such as fatigue, quality of sleep, cognition, multiplicity of symptoms, and extent of pain generators. One pertinent finding of the 2010 evaluation was that approximately 25% of patients with a previous diagnosis of FM did not satisfy 1990 ACR classification criteria at the time of the study; the performance of these criteria was not studied in a primary care setting [6] . These criteria were further modified in 2011 (2011ModCr) and allowed for self-administration of the criteria, which increased utility for clinical and epidemiologic studies without the use of an examiner [7] . An alternative set of diagnostic criteria (2013AltCr) have also been proposed, assessing a broader set of symptoms and pain conditions [8] .
Although criteria largely have been used for the purpose of producing a diagnosis [9] , their use in this context has been called into question [10] as some investigators consider FM to be a somatoform disorder [9, 11] . This is primarily because the cause of FM is unknown, and diagnosed patients may meet criteria for other pain or musculoskeletal syndromes. Many of the FM symptoms are commonly distributed across several rheumatic and nonrheumatic illnesses of varying types [10] . There is also concern about the influence of pharmaceutical companies as they have brought medications to market for this indication including pregabalin (LyricaV R , Pfizer) and duloxetine (CymbaltaV R , Lilly) which also possess psychotropic activity and are approved for other indications including anxiety, depression, and chronic pain [12, 13] . Any response attained by these agents may reinforce and validate the belief that symptoms are a manifestation of FM [14] , when it may actually be an antidepressant response [15] .
The incidence and association between psychiatric conditions and chronic pain [16, 17] , and FM in particular, are well established [18, 19] . Depression is commonly diagnosed in FM patients, but FM is uncommon in patients with major depression [20] . One study found anxiety disorders to be approximately five times more common in women with FM than those without [21] . This is consistent with a large general population survey that identified FM prevalence of approximately 2%, occurring predominantly in women with an incidence of 3.4%, with no distinction within different ethnic or social groups [2] . Patients with FM have demonstrated significantly higher lifetime prevalence rates of psychiatric diagnoses, ranging from 41% to 57% [18, 22] .
Clinicians are often challenged as to how to address both the physiological and psychological needs of FM patients who present with chronic pain. These patients frequently report morning stiffness, fatigue, and nonrestorative sleep, which can significantly affect quality of life and functional ability [5] . The symptoms, severity, and response to treatment vary greatly between individuals, but more than half of those diagnosed under 65 years of age report being unable to work because of their diagnosis [4] . When patients do not meet any conventionally accepted criteria for their widespread pain and/or suffering, or if a diagnostic label is inaccurately applied without consideration of concomitant psychosocial issues, a potential for misdiagnosis or mismanagement exists [15] . Using surrogate diagnostic criteria similar to the 2011 modified ACR criteria, the NHIS found that of those persons reporting a clinical diagnosis of FM, 73.5% did not meet diagnostic criteria [23] . In a separate evaluation, FM was diagnosed in 34% of cases [24] , and various inflammatory rheumatologic conditions accounted for almost half of misdiagnoses. In another study, previously undiagnosed spondyloarthropathies, particularly ankylosing spondylitis, were a contributing factor in 3% of subjects with a confirmed or presumed prior diagnosis of FM [25] .
The 2010 ACR criteria have been assessed in multiple populations worldwide [8, [26] [27] [28] , but have generally focused on those seen by specialty care providers, including rheumatology, as opposed to a primary care population. The purpose of this study was to assess the accuracy of a prior diagnosis of FM, comparing the 1990 ACR criteria with the 2010 revised criteria in a general medicine practice, and to compare the characteristics of patients in this population with a group with other forms of non malignant chronic pain.
Methods
This was a quantitative, hypothesis-testing, prospective cohort study, performed within the General Medicine Pain Service (GMPS), Division of General Medicine and Clinical Epidemiology, School of Medicine, at the University of North Carolina at Chapel Hill (UNC). One of three existing disease management clinics in the UNC General Medicine Clinic, this academic internal medicine practice offers multidisciplinary, disease-focused care for complex medical conditions; the other two are dedicated to anticoagulation and diabetes management [29] . The research protocol was approved by the Institutional Review Board and Office of Human Research Ethics at the UNC School of Medicine.
All study subjects were English-speaking ambulatory patients, internally referred, and selected from clinic records of patients currently attending the GMPS. Maximal enrollment ensured that the response rate was high and comparable with other studies with a specific subset of FM patients [22, 30] . All electronic health records (EHRs) of study patients were reviewed: Those with chronic nonmalignant pain and without a diagnosis of FM were identified and served as the potential control group population. Thirty-three patients given a diagnosis of FM before enrollment in the GMPS were identified and approached for potential study enrollment. The EHR of all study patients was reviewed to determine the existence of a diagnosis of a painful or inflammatory condition, as well as any psychiatric condition.
Every individual who attended the GMPS during a threemonth period who fulfilled inclusion criteria was eligible for the study and was entered into the study upon receipt of informed consent. In return for their time, patients received a two-hour free parking coupon upon completion of the study. Inclusion criteria for the FM study group required the individual to be currently attending the GMPS with a diagnosis of FM. Control group inclusion criteria required the individual to be currently attending the GMPS with an ongoing diagnosis of nonmalignant chronic pain that had not been diagnosed as FM. Exclusion criteria included active malignancy, age younger than 18 years, or inability to provide informed consent.
The incidence of FM, psychiatric conditions, and other forms of chronic pain have been documented to vary with both age and gender [2] . To reduce variance, individuals from both control and study groups were matched by age and gender. The matching process was randomized to reduce bias: Each group was sorted by sex and decade of age, and individuals from the control group were selected to match each member of the test group using an internet-based random integer generator [31] . Patient records were used to identify ethnicity and any incidence and type of previously diagnosed psychiatric conditions. These were only included if they were noted as active within patient medical records within the last five years. All study participants were assigned a unique identification number to maintain blindness and confidentiality.
The second stage was a structured telephone interview using a predetermined script, carried out by two trained research assistants who were blinded to the patient's diagnoses to minimize any potential bias. During the interview, patients completed questions from the Pain Disability Index (PDI) [32] , the Personal Health Questionnaire (PHQ-9) [33] , and the Revised Fibromyalgia Impact Questionnaire (FIQR) [34] .
Each study participant's literacy level was assessed using the standardized Rapid Estimate Adult Literacy in Medicine (REALM) test [35] as lower level skills are critical to identify when evaluating a disorder with a psychiatric overlay or involvement [36] . The REALM test was used because of the ease of administration, and it is well validated for use in a busy primary care setting [35] . The noninvasive physical examination began with the tender point examination from the 1990 ACR guidelines [5] . Patients were assessed further with a widespread pain index, as well as a symptom severity scale, consistent with the revised criteria protocol [6] , as results from a physical examination are more accurate than use of patient medical records alone.
Thirty-three patients with a working diagnosis of FM were identified, and of those, 26 (78.8%) agreed to participate in the study and met inclusion criteria. These patients were matched by age and gender to a control group of 26 patients with a diagnosis of other forms of chronic nonmalignant pain. One FM patient was excluded because of active malignancy, and others were excluded either because they did not provide informed consent or because they were unable to attend the clinic during the study period. The control comparisons were consequently excluded from the analysis.
Bivariate and multivariate analyses were performed using chi-square, one-way analysis of variance and linear regression tests and included between-group comparisons of mean FM tender points, widespread pain index, symptom severity, PDI, PHQ9, FIQR, and REALM scores. For those patients who fit the inclusion criteria, there were no missing data for the analyses or calculations. All statistical analyses were calculated using Stata 14 (v. 14.1, StataCorp, College Station, TX, USA).
Results
The identified study population was primarily Caucasian (75.0%) and female (80.8%), with an average age of 53.1 6 10.8. Additional demographic characteristics for both study patients and matched controls are summarized in Table 1 . In the FM group, 57.7% (N ¼ 15/26) of individuals had widespread pain, compared with 46.2% (N ¼ 12/26) of controls. The mean number of FM tender points identified was higher for the FM group (5.6 6 4.2) than controls (3.2 6 2.2) and was the only variable that was found to show a statistically significant difference between the two populations in any of the statistical analyses (P ¼ 0.002). When the 1990 ACR guidelines were applied within the physical examination, only three (11.5%) patients with a prior diagnosis of FM were found to meet the diagnostic criteria for FM, with none among the controls. All of these individuals were female, Caucasian, between 48 and 57 years of age, and belonged to the group of patients with a working diagnosis of FM. When the 2010 criteria were applied, 38.5% of FM patients met the diagnostic criteria; 
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however, 46.1% of control patients also scored sufficiently to meet the revised diagnostic criteria (Table 2) .
Although not statistically significant, the mean PDI score of the FM group, 47.1 (6 13.0), was slightly higher than that of the control group (44.6 6 12.8). In the FM group, PHQ-9 scores had a mean of 8.3 (6 8.6), suggesting that these individuals exhibited symptoms of mild depression. In comparison, controls had a higher mean score 11.3 (6 8.0), suggesting that individuals were exhibiting symptoms consistent with moderate depression. With the FIQR, the FM study group had a higher but nonsignificant mean score (67.8 6 12.7) compared with controls (64.6 6 15.8) as both groups were highly affected in their everyday lives by similar problems. Based on mean REALM scores, FM patients had a higher mean literacy level than controls. Although the difference was not statistically significant (P ¼ 0.454), their scores were equivalent to a seventh to eighth grade reading level.
The mean number of previously diagnosed psychiatric conditions was 2.08 (6 1.41) in the FM group, compared with 1.73 (6 1.22) in controls (P ¼ 0.466). Of interest, eight of 11 FM study patients who met the 2010 criteria (72.7%), and nine of 12 controls (75.0%), also had a prior diagnosis of depression. When considering both groups together, at least one previously diagnosed psychiatric condition was present in 80.8% of patients.
The incidence of the nine different types of conditions that were identified in the two groups is depicted in Table 3 . Depression (20.2%, vs 24.2% in controls) and anxiety (16.2%, vs 11.1%) were the most common psychiatric conditions identified in both study populations through direct screening and also EHR analysis.
Discussion
Only three (11.5%) study patients, all with a prior diagnosis of FM, met the outdated 1990 ACR classification criteria, reflecting other studies [6, 24, 37] . When the 2010 criteria were applied to both groups, however, a greater number tested positive: almost half (46.1%) of the control group also met the 2010 diagnostic criteria. Based upon the findings of this and other similar studies [24, 25] , all patients with a working diagnosis of FM should be reassessed to determine a correct diagnosis and reviewed to ensure that the most appropriate treatment is being provided.
Many patients self-identify as having FM. A demanding patient with a pre-existing knowledge of a disease state may introduce bias into their diagnosis and management [38, 39] . Promoting consistent use of validated diagnostic criteria, with appropriate clinical amendments [12] , may help prevent future misdiagnoses, validation, and labeling effects. In primary care, often without the input of rheumatologists, the labeling of patients with the diagnosis of FM is likely overused [24] , possibly as clinicians use this diagnosis too freely, without giving consideration to other possible musculoskeletal conditions such as myofascial pain syndrome [37] and various forms of arthritis [40] , or because they are unfamiliar with the FM diagnostic criteria or are unwilling to use them [41] .
The presence of psychiatric conditions such as a depressed mood have been shown to impede the pain treatment response in FM patients [42] . Patients with chronic diffuse pain have a significantly higher prevalence of depression and anxiety disorders [43] and are more than three times as likely to suffer from a concomitant psychiatric disorder, particularly mood disorders, when compared with the general population [44] . This is reflected by limited physical function, increased utilization of health care services by FM sufferers as a result of their pain [45] , and the benefits that are derived through involvement in programs that focus on exercise and cognitive behavioral therapy, instead of just pharmacotherapeutic modalities [46] .
As depression has been linked to the diagnosis of FM when using the outdated ACR criteria [47] , as well as opioid misuse and chronic pain [43, 48] , study investigators felt that a quantitative screening tool for depression should be included in this study. Other psychiatric conditions such as anxiety are also common in this patient population; however, PHQ-9 was preferred over other inventories because it is commonly used in primary care settings and actively screens for the risk of suicide [18] .
PDI, PHQ, REALM, and FIQR scores were not statistically significantly different between FM patients and controls, but if a larger sample size had been used, more significant differences between the two populations may have been identified. PDI, PHQ, and FIQR scores suggest that both populations suffer from depressive symptoms, with pain exhibiting a potentially significant impact upon their activities of daily living. These patients often pose a special therapeutic challenge, and many clinicians find it difficult to deny a patient requesting medication.
While opioid analgesics may be frequently used for FM, recommendations advocating this remain elusive, with some variance in international expert opinion [49] [50] [51] [52] [53] . In a study of patients with a diagnosis of FM, opioids did not provide sustained pain relief: Central sensitization was present, and tender points may represent secondary hyperalgesia [16] . Tramadol, a synthetic centrally acting analgesic, was shown in an industry-sponsored trial to relieve FM pain; however, its placebo comparator provided better overall pain relief scores [17] . Opioids should only be considered as a last resort following thorough evaluation of pain generators, rather than a pre-existing label of FM, because of limited evidence of efficacy, and indiscriminant use in such a patient population may increase the risk for opioid misuse.
This study is limited by several factors. The relatively small sample size limited the statistical power and subsequently may have limited the ability to distinguish a statistical difference between the control and FM groups. In this study, previous psychiatric diagnoses were identified using patient medical records, which is a potential source of inaccuracy and likely underestimated the incidence of concomitant psychiatric disorders. The incidence of individuals with at least one type of psychiatric diagnosis was 80.8% in both groups, consistent with other studies such as Walker et al., who identified 88.9% of their FM patients as having at least one diagnosis [30] . If a psychiatrist had completed assessments to confirm every prior diagnosis, this may have been more accurate, but far more time consuming and with major cost implications. Individuals with chronic pain conditions such as FM often have multiple psychiatric diagnoses, and they must be treated for these conditions in conjunction with FM. Study findings therefore support the need for chronic pain patients to receive regular screening for psychiatric comorbid conditions, and if identified, their management should be prioritized.
Although commonly diagnosed within the clinical setting, the validity of a diagnosis of FM has been questioned. Much discussion has focused on the foundation of the FM label being built on a sociocultural basis, without any actual evidence of unique pathophysiology [15] . The findings presented through this research shed light on the inconsistencies of the FM classification criteria, possibly leading to inaccurate diagnosis and subsequently inappropriate treatment. In addition to pharmacotherapy, it is necessary to address the psychosocial aspects of chronic pain patients, tailoring treatment to the individual and therefore promoting the highest standard of care.
Despite these limitations, the results of this evaluation may be generalizable to other chronic pain clinic populations within primary care settings. To draw further comparisons between patients with FM and other forms of nonmalignant chronic pain, future studies will require the use of a larger population, with the use of a standardized diagnostic process with updated ACR criteria. If evaluating the efficacy of various treatment options, scientific evaluations of various chronic pain syndromes need to be of sufficient length to adequately assess the duration of efficacy of the various modalities to be utilized, as well as long-term complications.
Those who did not meet ACR criteria in this study but who had been previously labeled as having FM are thought to have been subject to poorly managed coexisting psychiatric disorders, various forms of arthritis, neuropathy, or variation in symptoms over time (i.e., patients met criteria at the time of diagnosis, but no longer do so). Patients had received their FM diagnoses from a variety of health care providers, including rheumatologists, and many received the diagnosis several years (in some cases, decades) before attending the clinic and taking part in this study. Independent of the method of diagnosis, many clinicians accept FM as a chronic, lifelong condition, but variability in symptoms exists over time, which may have confounded the attempt to confirm the initial diagnosis in the vast majority of cases. With an imprecise application of the label of FM in a patient population with chronic pain, further use of the tender point examination should also be discouraged.
This study also calls into question the validity of the 2010 criteria, and further studies will continue to clarify this issue. For practitioners, the goal is to minimize the adverse consequences of labeling a patient as having FM and to gain a better understanding of the overall Fibromyalgia Diagnosis in General Practice management. With a more precise diagnosis, patients should be able to receive better treatment options that provide adequate analgesia, provide associated symptom relief, and manage concurrent psychiatric disorders.
